Dow, S&P 500, Nasdaq futures slide on reports US warship turned back in Hormuz

⚡ NuScale Power stock faces big week as earnings near and SMR rivals chase Big Tech

NuScale Power Corp. starts the week with its Q1 report on deck for May 7, with investors watching closely for signs of progress.

Shares last closed at $12.14, off 2.57% Friday. Since NuScale hasn’t shipped a commercial reactor module yet, investors are focusing less on profit and more on potential orders, funding, or concrete execution milestones.

This week is a big one for NuScale. The company is aiming to leverage momentum in nuclear power, driven by data-center growth, industrial electrification, and supportive U.S. policy, into signed deals for its small modular reactor technology.

Unlike traditional reactors, SMRs are compact units designed for scalable, repeatable deployment rather than custom-built mega facilities. TechStock² reports.


🏢 Applied Digital stock pulls back after $7.5 billion AI data-center deal — what comes next

Applied Digital Corp dipped 2.04% to close at $33.55 on Friday, with traders sizing up the recent surge in the AI data-center name against uncertainties around expansion expenses and timelines.

Shares swung between $35.15 and $33.30 through the session, and roughly 17.04 million shares changed hands.

This is notable: Applied Digital has emerged as a closely tracked player among the smaller firms riding the AI infrastructure wave.

The Dallas outfit isn’t just pitching an AI boom narrative — it’s working to convert lengthy lease deals into operational data-center space.

That means wrestling with power, cooling, and financing hurdles, all of which have to align for the plan to work. TechStock² reports.


🧬 Celcuity's Phase 3 VIKTORIA-1 trial achieves primary endpoint with clinically meaningful improvement

Celcuity Inc., a clinical-stage biotechnology company focused on targeted oncology therapies, announced positive topline results from the PIK3CA mutant cohort of its Phase 3 VIKTORIA-1 clinical trial.

The study evaluated gedatolisib plus fulvestrant with or without palbociclib in patients with hormone receptor positive, HER2-negative, PIK3CA mutant locally advanced or metastatic breast cancer following prior treatment with a CDK4/6 inhibitor and an aromatase inhibitor.

Detailed results will be presented in a late-breaking oral session at the American Society of Clinical Oncology Annual Meeting, scheduled for May 29 to June 2, 2026, in Chicago. Globe Newswire reports.


🧠 Nvidia rival Cerebras reloads IPO bid with $3.5 billion goal

Cerebras Systems Inc. is accelerating its push into the public markets to raise capital and strengthen its position in the rapidly expanding AI chip sector.

Cerebras plans to raise up to $3.5 billion through an initial public offering, offering 28 million shares priced between $115 and $125 each, according to its SEC filing.

The company revived its IPO efforts after withdrawing a previous registration and making a confidential filing earlier this year.

Investor interest appears strong, with banks reportedly receiving indications of demand exceeding $10 billion, Bloomberg reported, citing people familiar with the matter. Benzinga reports.


🧾 GameStop makes bold $56 bln play for eBay, ready to go hostile

GameStop proposed on Sunday to buy eBay for about $56 billion in a cash-and-stock deal, with CEO Ryan Cohen saying he was prepared to take the bid directly to shareholders should eBay's board be unreceptive.

GameStop is offering to pay $125 a share in a 50-50 mix of cash and stock, according to Cohen’s letter to eBay’s board. Based on eBay's Friday close, the bid represents a premium of about 20%. Reuters reports.

Time (ET)/ Report/ Period

10:00 AM - Factory orders - March
12:50 PM - New York Fed President John Williams speech - N/A

“You will never learn anything new until you admit you’re wrong.”

– Ray Dalio

Sourced in: Principles — GoodReads.

TradeZero America, Inc., a United States broker dealer, registered with the Securities and Exchange Commission (SEC) and member of the Financial Industry Regulatory Authority (FINRA) and the Securities Investor Protection Corporation (SIPC); TradeZero, Inc., a Bahamian broker dealer, registered with the Securities Commission of the Bahamas ; TradeZero Canada Securities ULC, a Canadian broker dealer, member firm of Canadian Investment Regulatory Organization (CIRO) and member of the Canadian Investor Protection Fund (CIPF); and TradeZero Europe B.V., a Dutch broker dealer, authorized and regulated by the Dutch Authority for the Financial Markets (AFM) (collectively, the “TradeZero Broker Dealers”).

TradeZero Broker Dealers offer self-directed electronic securities trading to their customers. TradeZero Broker Dealers do not provide financial or trading advice and do not make investment recommendations to their customers. This communication does not constitute an offer to sell or a solicitation to buy any security or instrument which it may reference. There is a risk of loss in online trading of securities including equities and options. Trading on margin is for experienced investors whereby the loss can be greater than your initial investment. Likewise, short selling as a securities trading strategy is extremely risky and can lead to potentially unlimited losses. Options trading is not suitable for all investors as it can involve risk that may expose investors to significant losses. Please read the Characteristics and Risks of Standardized Options, also known as the Options Disclosure Document (ODD) at OCC.

If you have any specific questions about TradeZero's brokerage services, please reach out to the TradeZero Broker Dealer servicing your jurisdiction.